Brainstorm Cell Therapeutics (BCLI) Stock Chart & Stock Price History → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free BCLI Stock Alerts $0.38 -0.02 (-5.00%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Brainstorm Cell Therapeutics Stock Price Performance5 Day Performance-29.58%1 Month Performance-43.70%3 Month Performance-2.56%6 Month Performance+122.22%Year-To-Date Performance+39.19%1 Year Performance-88.13% Receive BCLI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. BCLI Stock Chart for Saturday, May, 4, 2024 BCLI Chart by TradingView Brainstorm Cell Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$0.40$0.38-4.59%$0.43$0.37552,159 shs$25.97 million05/02/2024$0.43$0.40-8.33%$0.46$0.361.32 million shs$27.22 million05/01/2024$0.38$0.43+15.10%$0.54$0.421.92 million shs$29.69 million04/30/2024$0.54$0.38-30.04%$0.56$0.361.74 million shs$25.80 million04/29/2024$0.53$0.54+0.95%$0.55$0.5280,513 shs$36.88 million04/26/2024$0.53$0.53+0.47%$0.56$0.52265,170 shs$36.53 million Get the Latest News and Ratings for BCLI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$0.55$0.53-2.39%$0.56$0.52273,815 shs$36.36 million04/24/2024$0.53$0.55+3.81%$0.56$0.52201,562 shs$37.25 million04/23/2024$0.54$0.53-2.80%$0.56$0.51166,413 shs$35.88 million04/22/2024$0.53$0.54+1.52%$0.58$0.52365,604 shs$36.91 million04/19/2024$0.51$0.53+3.44%$0.61$0.451.01 million shs$36.36 million04/18/2024$0.54$0.51-4.90%$0.59$0.451.08 million shs$35.15 million04/17/2024$0.53$0.54+2.60%$0.59$0.53528,793 shs$36.96 million04/16/2024$0.55$0.53-3.94%$0.57$0.45622,189 shs$36.02 million04/15/2024$0.58$0.55-6.04%$0.60$0.54589,469 shs$37.50 million04/12/2024$0.58$0.58+1.20%$0.62$0.58263,963 shs$39.91 million04/11/2024$0.60$0.58-4.06%$0.67$0.541.39 million shs$39.44 million04/10/2024$0.58$0.60+3.26%$0.64$0.581.10 million shs$41.11 million04/09/2024$0.73$0.58-20.21%$0.74$0.574.71 million shs$39.81 million04/08/2024$0.65$0.73+12.14%$0.75$0.652.59 million shs$49.89 million04/05/2024$0.68$0.65-3.56%$0.69$0.63623,369 shs$31.89 million04/04/2024$0.69$0.68-2.07%$0.72$0.65713,516 shs$33.06 million04/03/2024$0.72$0.69-4.13%$0.72$0.67942,014 shs$33.76 million04/02/2024$0.74$0.72-2.82%$0.75$0.67600,184 shs$35.22 million04/01/2024$0.56$0.74+31.03%$0.75$0.591.43 million shs$36.24 million03/29/2024$0.56$0.56$0.60$0.48649,965 shs$27.66 million03/28/2024$0.60$0.56-5.91%$0.60$0.49647,340 shs$27.66 million03/27/2024$0.66$0.60-9.06%$0.69$0.511.28 million shs$29.40 million03/26/2024$0.66$0.66+0.76%$0.72$0.621.49 million shs$32.33 million03/25/2024$0.57$0.66+14.91%$0.79$0.574.64 million shs$32.08 million03/22/2024$0.48$0.57+18.75%$0.58$0.471.77 million shs$27.92 million03/21/2024$0.51$0.48-5.33%$0.56$0.401.80 million shs$23.51 million03/20/2024$0.36$0.51+42.54%$0.55$0.364.40 million shs$24.83 million03/19/2024$0.33$0.36+8.31%$0.37$0.33656,523 shs$17.42 million03/18/2024$0.33$0.33-1.35%$0.34$0.33361,486 shs$16.09 million03/15/2024$0.33$0.33+1.31%$0.34$0.33449,409 shs$16.31 million03/14/2024$0.33$0.33-0.60%$0.35$0.33325,171 shs$16.10 million03/13/2024$0.31$0.33+7.30%$0.36$0.32679,769 shs$16.19 million03/12/2024$0.33$0.31-6.35%$0.33$0.27231,754 shs$15.09 million03/11/2024$0.33$0.33-0.30%$0.34$0.32343,760 shs$16.11 millionAutomatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free.03/08/2024$0.35$0.33-5.15%$0.35$0.33405,177 shs$16.16 million03/07/2024$0.33$0.35+5.55%$0.35$0.32495,768 shs$17.04 million03/06/2024$0.35$0.33-5.34%$0.34$0.33242,466 shs$16.14 million03/05/2024$0.37$0.35-4.60%$0.37$0.321.84 million shs$17.06 million03/04/2024$0.35$0.37+5.74%$0.37$0.32399,491 shs$17.88 million03/01/2024$0.37$0.35-5.94%$0.37$0.34194,303 shs$16.91 million02/29/2024$0.37$0.37+0.11%$0.38$0.341.52 million shs$17.98 million02/28/2024$0.36$0.37+0.99%$0.37$0.35446,381 shs$17.96 million02/27/2024$0.36$0.36+1.14%$0.38$0.34744,600 shs$17.78 million02/26/2024$0.35$0.36+2.84%$0.37$0.312.49 million shs$17.58 million02/23/2024$0.33$0.35+5.60%$0.38$0.33506,731 shs$17.09 million02/22/2024$0.31$0.33+6.27%$0.34$0.32233,125 shs$16.19 million02/21/2024$0.36$0.31-13.61%$0.36$0.30867,661 shs$15.23 million02/20/2024$0.37$0.36-3.67%$0.38$0.34217,721 shs$17.63 million02/19/2024$0.37$0.37$0.38$0.34206,700 shs$18.30 million02/16/2024$0.39$0.37-3.69%$0.38$0.34206,773 shs$18.30 million02/15/2024$0.35$0.39+11.17%$0.39$0.33532,076 shs$19.00 million02/14/2024$0.34$0.35+4.18%$0.36$0.311.98 million shs$17.09 million02/13/2024$0.36$0.34-5.63%$0.37$0.32632,550 shs$16.41 million02/12/2024$0.38$0.36-5.33%$0.38$0.36288,018 shs$17.39 million02/09/2024$0.39$0.38-4.31%$0.39$0.36343,655 shs$18.37 million02/08/2024$0.38$0.39+2.06%$0.40$0.331.15 million shs$19.20 million02/07/2024$0.39$0.38-1.29%$0.39$0.32655,469 shs$18.81 million02/06/2024$0.38$0.39+2.37%$0.41$0.38334,080 shs$19.05 million02/05/2024$0.39$0.38-2.56%$0.40$0.38452,986 shs$18.61 million Related Companies: PLUR Stock Chart ZIVO Stock Chart ACHL Stock Chart AIM Stock Chart CRTX Stock Chart INAB Stock Chart APTO Stock Chart PMCB Stock Chart TARA Stock Chart INKT Stock Chart Receive BCLI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCLI) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.